Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth. [PDF]
, 1985 G Forni +2 more
openalex +1 more source
ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population
Folia Histochemica et Cytobiologica, 2011 There is strong evidence that altered immunological function entails an increased risk of B-cell chroniclymphocytic leukemia (B-CLL). The main mechanism of an anti-tumor response depends on T-cell activation.Unlike the constitutively expressed CD28 ...
Lidia Karabon +7 more
doaj
Effector Genes at the Coronary Artery Disease Risk Locus Harboring PDGFD and LncRNA AP002989.1. [PDF]
J Am Heart Assoc, 2023 Solomon CU, Yang W, Ye S.
europepmc +1 more source
Lymphokine activated killer (LAK) activity in normal pregnancy
, 1987 Shigeru Saito +3 more
openalex +2 more sources
Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients [PDF]
, 1994 Nobuya Karimine +5 more
openalex +1 more source
Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. [PDF]
, 1987 Holly Cherwinski +3 more
openalex +1 more source